{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:11:57Z","timestamp":1769159517630,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1067\/mjd.2000.108366","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:20:13Z","timestamp":1027556413000},"page":"1049-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris"],"prefix":"10.1067","volume":"43","author":[{"given":"Leela","family":"Engineer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash C.","family":"Bhol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Razzaque","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.108366_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-92-3-396","article-title":"Pemphigus: current concepts","volume":"92","author":"Ahmed","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2000.108366_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0190-9622(79)80050-X","article-title":"Pemphigus and pemphigoid","volume":"1","author":"Lever","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archderm.1942.01500150014002","article-title":"Pemphigus: a clinical analysis and follow-up study of sixty-two patients","volume":"46","author":"Lever","year":"1942","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1067\/mjd.2000.108366_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib5","first-page":"375","article-title":"Corticosteroids: a review with emphasis on complications of prolonged systemic therapy","volume":"62","author":"Truhan","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1067\/mjd.2000.108366_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0190-9622(85)70097-7","article-title":"Immunosuppressive agents for use in dermatology","volume":"12","author":"McDonald","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.134.1.80","article-title":"Dermatological uses of high-dose intravenous immunoglobulin","volume":"134","author":"Jolles","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/0003-4819-103-6-965_1","article-title":"Bullous pemphigoid and intravenous gammaglobulin","volume":"103","author":"Godard","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2000.108366_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0190-9622(89)80148-3","article-title":"High-dosage intravenous gammaglobulin: therapeutic failure in pemphigus and pemphigoid","volume":"20","author":"Tappeiner","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(08)80783-9","article-title":"Effects of intravenous \u03b3-globulin in pemphigus","volume":"22","author":"Humbert","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib12","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.1995.tb06952.x","article-title":"High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris","volume":"133","author":"Messer","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.1995.tb02631.x","article-title":"Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in 6 patients","volume":"133","author":"Beckers","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2133.1996.d01-949.x","article-title":"Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy","volume":"135","author":"Bewley","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib15","first-page":"852","article-title":"Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy","volume":"135","author":"Wever","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1365-2133.1998.02297.x","article-title":"Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?","volume":"138","author":"Colonna","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2133.1999.02817.x","article-title":"High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases","volume":"140","author":"Harman","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0190-9622(99)70516-5","article-title":"Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris","volume":"40","author":"Jolles","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.108366_bib19","first-page":"119","article-title":"Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders","volume":"74","author":"Mobini","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mjd.2000.108366_bib20","volume":"8","year":"1990"},{"key":"10.1067\/mjd.2000.108366_bib21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment of dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.108366_bib22","first-page":"228","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.108366_bib23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3476(85)80231-6","article-title":"Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin","volume":"106","author":"Bussel","year":"1985","journal-title":"J Pediatr"},{"key":"10.1067\/mjd.2000.108366_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(85)90400-3","article-title":"Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood","volume":"2","author":"Imbach","year":"1985","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.108366_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V72.1.121.121","article-title":"Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated infusions of gammaglobulin","volume":"72","author":"Bussel","year":"1988","journal-title":"Blood"},{"issue":"Suppl 4A","key":"10.1067\/mjd.2000.108366_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(87)90546-8","article-title":"Comparison of the efficacy of a 2-day and a 5-day schedule for infusing intravenous gammaglobulin in the treatment of immune thrombocytopenic purpura in adults","volume":"83","author":"Kurlander","year":"1987","journal-title":"Am J Med"},{"key":"10.1067\/mjd.2000.108366_bib27","first-page":"206","article-title":"Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of literature","volume":"52","author":"Bussel","year":"1987","journal-title":"Vox Sang"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200388235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200388235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:24:34Z","timestamp":1759267474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200388235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0190962200388235"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.108366","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.108366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}